2009 Davis Cup

sparks & honey Welcomes Two Leaders To Its Advisory Board, Experts In Purpose-Driven Business, Gender Justice, and Equity in Marketing & Advertising

Retrieved on: 
Wednesday, December 14, 2022
Movement, Science, Honey, Generation Z, International Academy, Wellness, Think Global, 2009 Davis Cup, Human, Advertising, Colorado State University, World Economic Forum, The Daily Dot, Marketing, New World Pasta, DE, Dell, News, Gen, Female, BIPOC, Health, Business Insider, Education, PepsiCo, Reproductive rights, Culture, Diageo, Digital art, Advisory board, Davos, CPG, The Advisory Board Company, Organization, Politics, Democracy, Food, Political movement, Senior, Software as a service, Omnicom Group, Management, Policy

The new Board members include President of Synastry Capital Janna Meyrowitz Turner and C-Suite Coach and Author Lola Bakare .

Key Points: 
  • The new Board members include President of Synastry Capital Janna Meyrowitz Turner and C-Suite Coach and Author Lola Bakare .
  • These new additions join a board of over 70 seasoned leaders and will help further build out the consultancy’s growing Policy & Philanthropy and Equitable Futures Practices.
  • Janna Meyrowitz Turner has been building values-aligned coalitions for over 20 years across CPG, fashion, tech, finance, entertainment, politics, advocacy, healthcare, wellness, food and more.
  • “We are delighted to welcome Lola to our Advisory Board as an Inclusive Marketing expert,” said Davianne Harris, Chief Client Officer and Head of Equitable Futures Practice at sparks & honey.

TFF Pharmaceuticals Announces Leadership Transition

Retrieved on: 
Monday, December 5, 2022
Nose, Acquisition, Interim, Absorption, Freezing, Powder, 2009 Davis Cup, IPO, Lung, Research, Maryland School, Tobacco Products Scientific Advisory Committee, Johnson & Johnson, FDA, Mount Sinai Hospital, Safety, Cancer, Skin, Vaccine, Inhalation, Johns Hopkins School of Medicine, Therapy, Alza, Johns Hopkins Hospital, Assistant, History of the University of Maryland, College Park, University, Patient, Degenerative disease, Janssen Biotech, TFF, Government, Latin honors, Memorial Sloan Kettering Cancer Center, Toxic tort, Risk, Internal medicine, Management, Pharmaceutical industry, Medicine

FORT WORTH, Texas, Dec. 05, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that Glenn Mattes will step down as Chief Executive Officer and Member of the Board of Directors. Dr. Harlan F. Weisman, Vice Chairman of the Board, has been appointed Interim Chief Executive Officer, effective December 5, 2022.

Key Points: 

    Arcutis Enrolls First Patient in Phase 1b Alopecia Areata Study Evaluating ARQ-255

    Retrieved on: 
    Monday, December 5, 2022
    Dermatitis, Janus kinase 1, Hair loss, Trial of the century, Inflammation, Atopic dermatitis, FDA, Safety, 2009 Davis Cup, Hair follicle, Skin, Pharmacokinetics, Hair, Recurrence, Dermatology, Face, Form 10-K, Alopecia areata, Risk, JAK1, Immune system, Scalp, Volunteering, Patient, Pharmaceutical industry

    “Alopecia areata is an immune condition that not only causes hair loss, but also causes significant negative impact on an individual’s emotional and mental wellbeing.

    Key Points: 
    • “Alopecia areata is an immune condition that not only causes hair loss, but also causes significant negative impact on an individual’s emotional and mental wellbeing.
    • Today, there are no FDA-approved topical therapies to treat the condition,” said Frank Watanabe, President and CEO at Arcutis.
    • ARQ-255, or topical invarmactiniib suspension, is a topical janus kinase 1 (JAK1) inhibitor therapy for alopecia areata.
    • Topical treatment of alopecia areata is challenging due to the depth of inflammation and the dense vasculature that surrounds the hair bulb.

    Roland Acra joins PsiQuantum as Chief Business Officer

    Retrieved on: 
    Wednesday, December 14, 2022
    Semiconductor, Technology, Other Technology, Other Science, Software, Science, Hardware, Cisco Systems, Transport, Agriculture, Silicon, Data center, Health, IPv6, Marketing, 2009 Davis Cup, Acquisition, Management

    Roland joins as Chief Business Officer and will lead the companys business strategy, including commercial, global market expansion, quantum applications and software development.

    Key Points: 
    • Roland joins as Chief Business Officer and will lead the companys business strategy, including commercial, global market expansion, quantum applications and software development.
    • Roland brings to PsiQuantum a distinguished track record in the technology industry spanning over 25 years.
    • He previously held the role of Chief Technology Officer at Cisco until earlier in 2022.
    • PsiQuantum and the PsiQuantum logo are registered or pending registration trademarks of PsiQuantum, Corp., in the United States and other countries.

    BNPL’s Meteoric Rise Spells Risk & Reward for Businesses, Marginalized Communities

    Retrieved on: 
    Wednesday, December 14, 2022
    Personal Finance, Technology, Payments, Other Retail, Finance, Fintech, Banking, Professional Services, Software, Retail, Travel, 2009 Davis Cup, Software, Generation X, Risk, Comparison, Consumer, Research, Generation Z, Multimedia, CFPB, African, Marketing, Capterra, Online shopping, Millennials

    Some experts say BNPL is taking advantage of financially illiterate shoppers; however, data shows that consumers understand the risks and can cover payments.

    Key Points: 
    • Some experts say BNPL is taking advantage of financially illiterate shoppers; however, data shows that consumers understand the risks and can cover payments.
    • View the full release here: https://www.businesswire.com/news/home/20221214005240/en/
      Despite acknowledging the Consumer Financial Protection Bureaus ( CFPB ) multiple risk advisories, most shoppers (57%) are more likely to use BNPL in the future.
    • The top three risk factors shoppers assess include hidden interest, credit score damage, and late fees.
    • Nearly half (45%) of Millennials, 33% of Gen Z, and 33% of Gen Xers financed at least one purchase using BNPL.

    DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions.

    Retrieved on: 
    Wednesday, December 14, 2022
    Biotechnology, Technology, Manufacturing, Health, Pharmaceutical, Health Technology, Other Science, Research, Artificial Intelligence, Science, Chemicals, Plastics, Laboratory, Ministry of Health, Nutrition and Indigenous Medicine, Lab, Innovation, Sartorius, Human, DSM (company), Science, Metadata, 2009 Davis Cup, Research, D, FAIR, Siri, Voice recognition, Deep learning, AI, DSM, Kerala University of Digital Sciences, Innovation and Technology, Multimedia, Record, Safety, Documentation, Health, Fine chemical

    DSM will apply the newly acquired technology in several of their Science & Innovation laboratories globally.

    Key Points: 
    • DSM will apply the newly acquired technology in several of their Science & Innovation laboratories globally.
    • Together, we intend to transform how science is performed in research and application labs providing significant value through speeding up innovation cycles at DSM and its partners worldwide.
    • View the full release here: https://www.businesswire.com/news/home/20221214005030/en/
      DSM partners with LabTwin to empower scientists with the latest voice and AI solutions.
    • The digital assistant will form part of DSMs wider digitalization strategy, including the full integration with DSMs Electronic Lab Notebooks.

    VinFast Chooses T-Mobile as Exclusive Global Connectivity Provider for Electric Vehicles

    Retrieved on: 
    Thursday, December 8, 2022
    Alternative Vehicles, Fuels, Mobile, Wireless, Technology, EV, Electric Vehicles, Vehicle Technology, Automotive, Automotive Manufacturing, Manufacturing, Networks, IOT (Internet of Things), Maintenance, T-Mobile, VinFast, UN, VF-6, Metro, Software, Transport, Life, Automation, Electric vehicle, Partnership, Social enterprise, LTE, Multimedia, Safety, Wi-Fi, Movement, TMUS, 2009 Davis Cup, Mobile phone, Mobile phone operator, Vingroup, Sprint

    Today, T-Mobile (NASDAQ: TMUS) and VinFast announced an agreement for the Un-carrier to be the exclusive provider of connectivity for VinFast's smart electric vehicles in North America and Europe.

    Key Points: 
    • Today, T-Mobile (NASDAQ: TMUS) and VinFast announced an agreement for the Un-carrier to be the exclusive provider of connectivity for VinFast's smart electric vehicles in North America and Europe.
    • View the full release here: https://www.businesswire.com/news/home/20221208005609/en/
      VinFast Chooses T-Mobile as Exclusive Global Connectivity Provider for Electric Vehicles (Photo: Business Wire)
      Under the agreement, T-Mobile will provide connectivity for VinFast's electric vehicles in North America and Europe, including the VF 6, VF 7, VF 8 and VF 9.
    • VinFast's goal is to turn our smart electric vehicles into a platform that connects every aspect of life, said Mdm.
    • To learn more about VinFast electric vehicles, visit: www.vinfastauto.us
      For more information about T-Mobile IoT, visit: www.t-mobile.com/business/solutions/iot
      VinFast a member of Vingroup envisioned to drive the movement of global smart electric vehicle revolution.

    Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations

    Retrieved on: 
    Thursday, December 15, 2022
    Heart, Health, 2009 Davis Cup, Cancer, Heart failure, Cardiology, AIDS, Hudson Valley, Albert Einstein College of Medicine, Pediatrics, Woman, Epidemiology, Hypertension, Teaching hospital, Student, Risk, NIH, Partnership, National Heart, Lung, and Blood Institute, College, Death, Obesity, Trial of the century, Ageing, Hospital, Liver disease, Transplant, Aorta, Framingham Heart Study, Lung, College of Medicine (UK), Diabetes, Black, Montefiore Medical Center, Doctor of Philosophy, Albert Einstein, Patient, University Hospital (Newark, New Jersey), Research, Incidence, Medicine, Degenerative disease, Neuroscience, Pharmaceutical industry, Medical device, Montefiore

    , principal investigator on the grant, professor of medicine and of epidemiology & population health at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore.

    Key Points: 
    • , principal investigator on the grant, professor of medicine and of epidemiology & population health at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore.
    • "This funding will help us better understand and predict heart failure among Hispanicsand potentially other population groups."
    • Compared with non-Hispanic whites, Hispanics/Latinos have a higher incidence of heart failure, tend to develop heart failure earlier, and tend to have more comorbidities accompanying heart disease, such as diabetes, obesity and hypertension.
    • Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.

    Guilin sets the stage

    Retrieved on: 
    Thursday, December 15, 2022
    Water, Pu Songling, Music, Song dynasty, Grand, Tree, Kunqu, Central Academy, Flower, Wood, 2009 Davis Cup, Grand Canal, Canglang Pavilion, Romance, Historical capitals of China, Ouyang, Six Records of a Floating Life, Nuo opera, Parent, Drama, History, Exhibition, Multimedia, Central Academy of Drama, Zhang Xincheng, Museum of the War of Chinese People's Resistance Against Japanese Aggression, Peking opera, Male, Film, Nightclub, Entertainment

    It will stage 29 theatrical productions, indoor and outdoor, at 10 locations in Guilin.

    Key Points: 
    • It will stage 29 theatrical productions, indoor and outdoor, at 10 locations in Guilin.
    • It will become a platform for global artists as well as serving as an opportunity to train young theater talent," says Yang Yanyan, head of the publicity department of Guilin, one of the organizers of the Guilin Festival.
    • Audiences enjoyed both the performances and the great view," says Hu, adding that it was the first time to stage his work in Guilin.
    • Theatrical Guilin, which features Guiju Opera artists from Guilin, will be staged on Dec 15 and 16.

    Statement on Aortic Aneurysm Reflecting on the Death of Grant Wahl

    Retrieved on: 
    Wednesday, December 14, 2022
    Ehlers–Danlos syndromes, Heart, CT, Degenerative disease, MD, Cardiology, Marfan syndrome, American Heart Association, American College, Life, Diagnosis, Skin, The Marfan Foundation, Washington University School of Medicine, MRI, Blood, Thoracic aortic aneurysm, Science, 2009 Davis Cup, Friends, Dissection, American College of Cardiology, Death, Wahl, Aortic aneurysm, Barnes-Jewish Hospital, Family, Nonsyndromic deafness, Intelligence, Child, Aneurysm, Woman, Multimedia, TAA, Microdeletion syndrome, Education, Pain scale, RENT, Connective tissue, Genetic testing, Joint, Blood vessel, Nervous system, Risk, Medical device, Pharmaceutical industry, Hospital

    NEW YORK, Dec. 14, 2022 /PRNewswire/ -- The Marfan Foundation is saddened to learn that journalist Grant Wahl has died due to complications of an ascending thoracic aortic aneurysm.  Diagnosed, this condition can be treated if people and their health professionals know the risk and manageable complications.

    Key Points: 
    • NEW YORK, Dec. 14, 2022 /PRNewswire/ -- The Marfan Foundation is saddened to learn that journalist Grant Wahl has died due to complications of an ascending thoracic aortic aneurysm.
    • We commit to continued investment in science, patient support, and collaborative efforts that will make these tragic moments fewer and fewer.
    • Recently, the American Heart Association and American College of Cardiology published new guidelines for identifying and treating aortic disease.
    • The Foundation, established more than 40 years ago, has been the leading advocate for aortic disease awareness and education since the death of Jonathan Larson, composer and playwright of RENT, who died of an undiagnosed aortic aneurysm and aortic dissection in 1995.